Growth Metrics

NovaBridge Biosciences (NBP) Long-Term Deferred Tax (2017 - 2022)

NovaBridge Biosciences (NBP) reported Long-Term Deferred Tax of $2.5 million for Q4 2022, down 53.41% on a QoQ basis from $5.4 million in Q4 2018.

NovaBridge Biosciences (NBP) has 3 years of Long-Term Deferred Tax data on file, last reported at $2.5 million in Q4 2022.

  • Quarterly Long-Term Deferred Tax changed N/A year-over-year to $2.5 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $2.5 million (changed N/A YoY) and the FY2022 annual result came in at $2.6 million, changed N/A from the prior year.
  • Long-Term Deferred Tax retreated to $2.5 million in Q4 2022 per NBP's latest filing, from $5.4 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $5.4 million in Q4 2018 and bottomed at $2.5 million in Q4 2022.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 2.51 Mn
Dec 31, 2018 5.38 Mn
Dec 31, 2017 5.62 Mn